Cite

HARVARD Citation

    Noth, I. et al. (n.d.). M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials. Thorax. pp. A255-A257. [Online]. 
  
Back to record